second quarter 2026
Filed Aug 4, 2026IPG Photonics Announces Second Quarter 2026 Financial Results
Revenue increased 11% year over year and adjusted EBITDA increased 54%, while GAAP net income decreased 21% and Advanced Solutions sales decreased 9%.
Key metrics
as reported| Metric | Value | q/q | y/y |
|---|---|---|---|
| RevenueGAAP | $278.6 million | – | 11% |
| Cost of salesGAAP | $166,056 | – | – |
| Gross profitGAAP | $112,524 | – | – |
| Gross marginGAAP | 40.4% | – | – |
| Adjusted gross marginnon-GAAP | 40.7% | – | – |
| Sales and marketing expenseGAAP | $23,818 | – | – |
| Research and development expenseGAAP | $31,004 | – | – |
| General and administrative expenseGAAP | $36,545 | – | – |
| Settlement of litigation mattersGAAP | $(166) | – | – |
| Impairment chargesGAAP | $17,574 | – | – |
| Gain on foreign exchangeGAAP | $(782) | – | – |
| Total operating expensesGAAP | $107,993 | – | – |
| Operating incomeGAAP | $4.5 million | – | NM |
| Operating marginGAAP | 1.6% | – | – |
| Interest income, netGAAP | $7,110 | – | – |
| Other income, netGAAP | $900 | – | – |
| Total other incomeGAAP | $8,010 | – | – |
| Income before provision for income taxesGAAP | $12,541 | – | – |
| Provision for income taxesGAAP | $7,299 | – | – |
| Net incomeGAAP | $5.2 million | – | (21)% |
| Earnings per diluted shareGAAP | $0.12 | – | (25)% |
| Earnings per basic shareGAAP | $0.12 | – | – |
| Adjusted EBITDAnon-GAAP | $48.5 million | – | 54% |
| Adjusted earnings per diluted sharenon-GAAP | $0.58 | – | 93% |
| Weighted average common shares outstanding, basicGAAP | 42,470 | – | – |
| Weighted average common shares outstanding, dilutedGAAP | 42,913 | – | – |
Segments
| Segment | Revenue | q/q | y/y |
|---|---|---|---|
| Industrial SolutionsGrowth in welding, marking, cleaning and additive manufacturing applications. | $237,043 | – | 16% |
| Advanced SolutionsLower revenue in micromachining and defense applications, partially offset by increased sales in semiconductor applications. | 41,537 | – | (9)% |
third quarter of 2026 outlook
- Revenue$265 million to $295 million
- Gross marginadjusted gross margin between 37.5% and 40.5%
- Operating expensesadjusted operating expenses of $92 million to $95 million
- NoteAdjusted earnings per diluted share in the range of $0.30 to $0.60
- NoteAdjusted EBITDA in the range of $35 million to $51 million
- NoteAssumes exchange rates relative to the U.S. dollar of euro 0.88, Japanese yen 162 and Chinese yuan 6.81, respectively.
What drove it
- Changes in foreign exchange rates increased revenue by approximately 2%.
- Industrial Solutions accounted for 85% of total revenue.
- Emerging growth products accounted for 58% of total revenue, up from 53% in the prior quarter.
- Sales increased 19% in Asia and 5% in Europe, while decreasing 2% in North America on a year-over-year basis.
- GAAP gross margin and adjusted gross margin increased year over year, driven by lower product costs, lower inventory provisions, and $4.7 million in tariff refunds recorded in the period.
- Book-to-bill remained above one in the second quarter.
Concerns
- Advanced Solutions sales decreased 9% year over year.
- GAAP net income decreased 21% year over year and GAAP earnings per diluted share decreased 25%.
- The company recorded $17,574 of impairment charges.
- The current uncertainty related to the trade environment and tariff policies increases the risks to the outlook provided.
- Guidance identifies trade policy changes and trade restrictions, product demand, order cancellations and delays, competition, tariffs and retaliatory tariffs, currency fluctuations and general economic conditions as factors that could affect actual results.
What to watch
- Industrial Solutions demand across welding, marking, cleaning and additive manufacturing applications.
- Advanced Solutions sales in semiconductor applications, micromachining and defense applications.
- The progression of emerging growth products, which accounted for 58% of total revenue.
- Adjusted gross-margin performance against the third-quarter range of 37.5% to 40.5%.
- The impact of trade environment uncertainty and tariff policies on demand, costs and results.
- The recently announced acquisition of Lumibird Medical and its strategic expansion into medical markets in Advanced Solutions.
Balance sheet and cash flow
- Cash and cash equivalents of $399,225 as of June 30, 2026, compared with $403,790 as of December 31, 2025.
- Short-term investments of 472,094 as of June 30, 2026, compared with 435,538 as of December 31, 2025.
- Long-term investments of 32,693 as of June 30, 2026, compared with 76,533 as of December 31, 2025.
- Total assets of $2,424,567 as of June 30, 2026, compared with $2,424,280 as of December 31, 2025.
- IPG generated $37.8 million in cash flow from operations during the second quarter.
- IPG spent $20.7 million on capital expenditures during the second quarter.
Analysis
IPG reported second-quarter revenue of $278.6 million, up 11% year over year, marking its third consecutive quarter of double-digit year-over-year revenue growth according to management. Industrial Solutions was the principal source of growth, with sales of $237,043, up 16%, supported by welding, marking, cleaning and additive manufacturing applications. Changes in foreign exchange rates increased revenue by approximately 2%.
The revenue mix was uneven. Industrial Solutions accounted for 85% of total revenue, while Advanced Solutions sales of 41,537 decreased 9% year over year. The Advanced Solutions decline reflected lower micromachining and defense revenue, partly offset by increased semiconductor-application sales. Emerging growth products accounted for 58% of total revenue, compared with 53% in the prior quarter. Regionally, sales increased 19% in Asia and 5% in Europe, while North America sales decreased 2% year over year.
Margins and adjusted earnings improved, but GAAP profitability remained constrained. GAAP gross margin increased to 40.4% from 37.3%, and adjusted gross margin increased to 40.7% from 37.8%, driven by lower product costs, lower inventory provisions and $4.7 million in tariff refunds. Adjusted EBITDA increased 54% to $48.5 million and adjusted earnings per diluted share increased 93% to $0.58. GAAP operating income was $4.5 million, while GAAP net income declined 21% to $5.2 million and diluted EPS declined 25% to $0.12. The period included $17,574 of impairment charges.
Cash flow from operations was $37.8 million, and capital expenditures were $20.7 million during the quarter. Cash and cash equivalents were $399,225 as of June 30, 2026, compared with $403,790 as of December 31, 2025. For the third quarter, IPG guided revenue to $265 million to $295 million, adjusted gross margin to 37.5% to 40.5%, adjusted operating expenses to $92 million to $95 million, adjusted EPS to $0.30 to $0.60 and adjusted EBITDA to $35 million to $51 million. Management said book-to-bill remained above one, but identified elevated uncertainty from trade conditions and tariff policies as a risk to the outlook.
Management, verbatim
We delivered our third consecutive quarter of double-digit year-over-year revenue growth, with revenue above the midpoint of our guidance and adjusted gross margin and adjusted EPS above our expectations.
Dr. Mark Gitin, Chief Executive Officer of IPG Photonics
Our book-to-bill remained above one in the second quarter, pointing to ongoing robust demand for our solutions and the team's focused execution of our growth strategy.
Dr. Mark Gitin, Chief Executive Officer of IPG Photonics
Not in the filing
stated, not guessed- Previous-period outlook was not provided; comparison of actual results with prior guidance is unavailable.
- Free cash flow was not reported.
- Share repurchases and dividends during the period were not reported.
- Debt was not reported in the provided filing text.
- Third-quarter tax-rate guidance was not reported.
- Quarter-over-quarter revenue, segment revenue, margin, earnings and cash-flow comparisons were not reported for the applicable line items.
- A GAAP operating-expense guidance figure was not reported.
- The provided filing text is truncated after the balance-sheet total-liabilities line; complete liabilities and equity details are unavailable.
AlphaAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.